Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 10;15(2):e34837.
doi: 10.7759/cureus.34837. eCollection 2023 Feb.

Prognostic Relationship Between the ABO Blood Groups and Metastatic Gastric Cancer

Elif Tugba Tuncel  1 , Engin Kut  2
Affiliations

Prognostic Relationship Between the ABO Blood Groups and Metastatic Gastric Cancer

Elif Tugba Tuncel et al. Cureus. .

Abstract

Aim: Gastric cancer is one of the most common malignant tumors of the digestive system and has a poor prognosis. Since recurrence and distant metastasis are common in gastric cancer, it is important to use practical and reliable prognostic parameters. In this study, the prognostic relationship between the ABO blood groups and metastatic gastric cancer was investigated.

Method and material: Data were collected by retrospectively scanning the files of 225 patients who were followed up with the diagnosis of metastatic gastric cancer in 2010-2022. The patients' demographic data (age, gender), tumor histopathology, tumor location, and ABO and Rh blood groups were evaluated.

Results: Of the patients, 138 (61.3%) were male and 87 (38.7%) were female. According to the distribution of the ABO system, blood group A was present in 109 (48.4%) patients, B in 33 (14.7%), AB in 20 (8.9%), and O in 63 (28%). Signet ring cell carcinoma, antrum tumor localization, and distant metastasis were more common in blood groups A and O. According to both the univariate and multivariate analyses, overall survival (OS) was statistically worse in patients with signet ring cell carcinoma and peritoneal metastasis (p < 0.05). The OS rate was the worst in blood group A and best in blood groups AB and B.

Conclusion: In this study, blood group A presented as both a risk factor and a poor prognostic factor in the development of metastatic gastric cancer. In addition, signet ring cell histopathology and presence of metastasis were found to be more common in patients with blood group A and associated with a poor prognosis. Blood groups are inexpensive, easily available, and reliable parameters that can provide an idea about both prognosis and survival in gastric cancer. Therefore, they can serve as a guide for clinicians in the follow-up and evaluation of the prognosis of these patients.

Keywords: abo blood groups; advanced gastric cancer; histopatology; prognosis; tumor location.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Kaplan‐Meier analysis of the relationship between the ABO blood groups and overall survival (5 year OS).
OS, overall survival
See this image and copyright information in PMC

References

    1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. CA Cancer J Clin. 2021;71:209–249. - PubMed
    1. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. Morgan E, Arnold M, Camargo MC, et al. EClinicalMedicine. 2022;47:10140. - PMC - PubMed
    1. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Gut. 2020;69:823–829. - PMC - PubMed
    1. Prognostic factors for survival in node-negative gastric cancer patients who underwent curative resection. Zhou Y, Cui JG, Huang F, et al. Scand J Surg. 2017;106:235–240. - PubMed
    1. Differences in gastric cancer survival between the U.S. and China. Strong VE, Wu AW, Selby LV, et al. J Surg Oncol. 2015;112:31–37. - PMC - PubMed

LinkOut - more resources